Cerritos, CA – Dietary supplement contract manufacturer Captek Softgel International, has acquired J+D Labs Pharma Manufacturing for an undisclosed price.
Captek is a portfolio company of Swander Pace Capital and this acquisition, announced by SPC, continues the firm’s focus on investing in and growing industry-leading vitamin, mineral and supplement companies.
Most recently, J+D Labs has brought to market NutraStock®, more than 250 bulk stock dietary supplements manufactured in the USA.
Captek CEO David Wood said in a press release that the union will result in a greater diversity of offerings and services within the supplement channel.
“We have long regarded J+D Labs’ reputation and the significance of what they bring to the table as a leader in the industry,” he said. J+D Labs’ extensive experience manufacturing a wide-range of softgels, specialized tablets, capsules, and powder formulations was a perfect complement to Captek’s offerings, he added.
“This acquisition is positive for everyone: for our employees, our suppliers, our customers, and the end-users,” said J+D Labs owner, Jay Majmudar. CSI is well-established in more than 20 countries. “We are happy to play a key role in helping to expand distribution even further. We will continue to make quality, price, and timely delivery a top priority,” Majmudar added.
The newly joined companies offer more than 300,000 square feet of manufacturing, warehousing, and analytical testing labs in California.
(Published on WholeFoods Magazine Online, 8/4/17)